Home About Physicians Patients Investors News Login

Renal Care Group Reports First Quarter Revenue Growth of 18%

NASHVILLE, Tenn.--(BW HealthWire)--April 30, 2002--Renal Care Group, Inc. (NYSE:RCI - news) today announced results for the first quarter ended March 31, 2002.

Mr. Sam Brooks, president and chief executive officer of Renal Care Group, said, "Based on the first quarter's results, I am confident of our team's ability to realize our objective of at least 15% growth in earnings per share for 2002. Same-store revenue growth, combined with acquisition activity, has resulted in a strong first quarter."

For the first quarter ended March 31, 2002, Renal Care Group's revenues increased 18.3% to $206.7 million compared with revenues of $174.8 million for the same period in 2001. Net income for the first quarter of 2002 rose 21.3% to $21.5 million from $17.7 million in the same period last year. Earnings per share for the first quarter of 2002 increased 16.7% to $0.42 compared with earnings per share of $0.36 in the same quarter of last year. For the quarter ended March 31, 2002, same-store treatment growth was 5.8% and same-store revenue growth was 13.9%.

During the first quarter, the Company acquired three dialysis programs, representing a total of six centers located in Ohio, Missouri and Indiana. These centers serve approximately 355 patients. In addition, in April, the Company acquired Philadelphia, Pennsylvania-based Delaware Valley Dialysis, a physician-owned company that provides dialysis services to approximately 275 patients, as well as dialysis services to inpatients at three Philadelphia hospitals.

Renal Care Group will hold a conference call to discuss this press release on Wednesday, May 1, 2002, at 10:00 a.m. Central Time. A listen-only simulcast, as well as a 30-day replay, of the conference call to discuss this press release will be available online at the Company's website at www.renalcaregroup.com or www.companyboardroom.com.

Renal Care Group, Inc. is a dialysis services company that provides care to patients with kidney disease. The Company currently treats approximately 19,200 patients through more than 240 owned outpatient dialysis facilities, in addition to providing acute dialysis services to more than 120 hospitals. Over 6,000 associates provide services across the Company's 26-state network.

Certain statements in this press release, particularly the statements of Mr. Brooks, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements, including risks related to: changes in the Medicare and Medicaid programs; risks related to EPO; payment reductions by private insurers, hospitals or managed care organizations; compliance with health care and other applicable laws; the integration of acquired companies; and changes in the health care delivery, financing or reimbursement systems. These and other factors affecting the company are discussed in more detail in Renal Care Group's reports filed with the Securities and Exchange Commission, including Renal Care Group's annual report on Form 10-K for the year ended December 31, 2001. Copies of Renal Care Group's SEC filings are available from Renal Care Group upon request.

                        RENAL CARE GROUP, INC.
                    Consolidated Income Statements
       (in thousands, except per share data and operating data)

                                                 Three Months Ended
                                                      March 31,
                                                 2002          2001
                                               --------      --------
Net revenue                                    $206,678      $174,778
Operating costs and expenses:
 Patient care costs                             134,712       113,328
 General and administrative expense              17,560        15,003
 Provision for doubtful accounts                  5,484         4,800
 Depreciation and amortization                    9,362         8,852
                                               --------      --------
  Total cost and expenses                       167,118       141,893

Income from operations                           39,560        32,795

Interest expense                                    173           999
                                               --------      --------

Income before minority interest
 and income taxes                                39,387        31,796

Minority interest                                 4,710         3,130
                                               --------      --------

Income before income taxes                       34,677        28,666

Income taxes                                     13,184        10,952
                                               --------      --------

Net income                                      $21,493       $17,714
                                               ========      ========

Diluted earnings per share                        $0.42         $0.36
                                               ========      ========

Weighted average shares outstanding              51,222        49,611
                                               ========      ========

Operating Data:

Patients                                         19,226        17,004
Treatments                                      707,483       644,146

Same-Store Treatment Growth                         5.8%          6.1%
Same-Store Revenue Growth                          13.9%         12.0%

Patient Revenue Per Treatment                      $290          $267


                        RENAL CARE GROUP, INC.
                      Consolidated Balance Sheets
                            (in thousands)

                                              March 31,      Dec. 31,
                                                 2002          2001
                                              ---------      --------
ASSETS:
Current assets:
 Cash and cash equivalents                      $55,520       $27,423
 Accounts receivable, net                       133,913       127,056
 Other current assets                            45,191        58,828
                                              ---------      --------
  Total current assets                          234,624       213,307

Property, plant and equipment, net              180,507       175,925
Intangibles and other assets, net               265,806       263,025
                                              ---------      --------

  TOTAL ASSETS                                 $680,937      $652,257
                                              =========      ========

LIABILITIES AND STOCKHOLDERS' EQUITY:
Total current liabilities                      $114,763      $110,468
Long-term debt                                    3,658         3,776
Other liabilities                                32,550        27,762
                                              ---------      --------
  Total liabilities                             150,971       142,006
                                              ---------      --------

Stockholders' equity:
 Common stock, $.01 par value,
  90,000 shares authorized, 49,847 and
  49,597 shares issued, respectively                499           496
 Treasury stock, 380 and 100
  shares, respectively                          (11,368)       (3,059)
 Additional paid-in capital                     283,828       277,300
 Retained earnings                              257,007       235,514
                                              ---------      --------

  Total stockholders' equity                    529,966       510,251
                                              ---------      --------
  TOTAL LIABILITIES AND
     STOCKHOLDERS' EQUITY                      $680,937      $652,257
                                              =========      ========

Contact:
Renal Care Group Inc., Nashville
R. Dirk Allison, 615/345-5500

Press Releases
Fresenius Medical Care Press Releases  Go
Renal Care Group Press Releases
- 2006
- 2005
- 2004
- 2003
- 2002
- 2001
- 2000
- 1999
- 1998
- 1997
- 1996

©2005-2006 Fresenius Medical Care. All rights reserved.